These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
404 related articles for article (PubMed ID: 28326803)
1. When Is an Alveolar Type 2 Cell an Alveolar Type 2 Cell? A Conundrum for Lung Stem Cell Biology and Regenerative Medicine. Beers MF; Moodley Y Am J Respir Cell Mol Biol; 2017 Jul; 57(1):18-27. PubMed ID: 28326803 [TBL] [Abstract][Full Text] [Related]
2. Stem cell biology and regenerative medicine for neonatal lung diseases. Kang M; Thébaud B Pediatr Res; 2018 Jan; 83(1-2):291-297. PubMed ID: 28922348 [TBL] [Abstract][Full Text] [Related]
3. The Oxygen Environment at Birth Specifies the Population of Alveolar Epithelial Stem Cells in the Adult Lung. Yee M; Gelein R; Mariani TJ; Lawrence BP; O'Reilly MA Stem Cells; 2016 May; 34(5):1396-406. PubMed ID: 26891117 [TBL] [Abstract][Full Text] [Related]
4. Generation of an alveolar epithelial type II cell line from induced pluripotent stem cells. Tamò L; Hibaoui Y; Kallol S; Alves MP; Albrecht C; Hostettler KE; Feki A; Rougier JS; Abriel H; Knudsen L; Gazdhar A; Geiser T Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L921-L932. PubMed ID: 30211653 [TBL] [Abstract][Full Text] [Related]
5. Harnessing the potential of lung stem cells for regenerative medicine. McQualter JL; Anthony D; Bozinovski S; Prêle CM; Laurent GJ Int J Biochem Cell Biol; 2014 Nov; 56():82-91. PubMed ID: 25450456 [TBL] [Abstract][Full Text] [Related]
6. In Vitro Disease Modeling of Hermansky-Pudlak Syndrome Type 2 Using Human Induced Pluripotent Stem Cell-Derived Alveolar Organoids. Korogi Y; Gotoh S; Ikeo S; Yamamoto Y; Sone N; Tamai K; Konishi S; Nagasaki T; Matsumoto H; Ito I; Chen-Yoshikawa TF; Date H; Hagiwara M; Asaka I; Hotta A; Mishima M; Hirai T Stem Cell Reports; 2019 Mar; 12(3):431-440. PubMed ID: 30773483 [TBL] [Abstract][Full Text] [Related]
7. The in vitro generation of lung and airway progenitor cells from human pluripotent stem cells. Huang SX; Green MD; de Carvalho AT; Mumau M; Chen YW; D'Souza SL; Snoeck HW Nat Protoc; 2015 Mar; 10(3):413-25. PubMed ID: 25654758 [TBL] [Abstract][Full Text] [Related]
8. Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases. Ikonomou L; Wagner DE; Turner L; Weiss DJ Ann Am Thorac Soc; 2019 Jun; 16(6):657-668. PubMed ID: 30917290 [TBL] [Abstract][Full Text] [Related]
9. Long-Term Engraftment Promotes Differentiation of Alveolar Epithelial Cells from Human Embryonic Stem Cell Derived Lung Organoids. Chen Y; Feng J; Zhao S; Han L; Yang H; Lin Y; Rong Z Stem Cells Dev; 2018 Oct; 27(19):1339-1349. PubMed ID: 30009668 [TBL] [Abstract][Full Text] [Related]
10. Keratinocyte growth factor and dexamethasone plus elevated cAMP levels synergistically support pluripotent stem cell differentiation into alveolar epithelial type II cells. Schmeckebier S; Mauritz C; Katsirntaki K; Sgodda M; Puppe V; Duerr J; Schubert SC; Schmiedl A; Lin Q; Paleček J; Draeger G; Ochs M; Zenke M; Cantz T; Mall MA; Martin U Tissue Eng Part A; 2013 Apr; 19(7-8):938-51. PubMed ID: 23176317 [TBL] [Abstract][Full Text] [Related]
11. Past and future of alveolar organoids for lung regenerative medicine. Mikawa R; Gotoh S Stem Cells; 2024 Jun; 42(6):491-498. PubMed ID: 38526067 [TBL] [Abstract][Full Text] [Related]
12. Acellular lung scaffolds direct differentiation of endoderm to functional airway epithelial cells: requirement of matrix-bound HS proteoglycans. Shojaie S; Ermini L; Ackerley C; Wang J; Chin S; Yeganeh B; Bilodeau M; Sambi M; Rogers I; Rossant J; Bear CE; Post M Stem Cell Reports; 2015 Mar; 4(3):419-30. PubMed ID: 25660407 [TBL] [Abstract][Full Text] [Related]
13. The LUNGe to Model Alveolar Lung Diseases in a Dish. Wang Z; Tang N Cell Stem Cell; 2017 Oct; 21(4):413-414. PubMed ID: 28985518 [TBL] [Abstract][Full Text] [Related]
14. Differentiation of Urine-Derived Human Induced Pluripotent Stem Cells to Alveolar Type II Epithelial Cells. Wang C; Hei F; Ju Z; Yu J; Yang S; Chen M Cell Reprogram; 2016 Feb; 18(1):30-6. PubMed ID: 26679635 [TBL] [Abstract][Full Text] [Related]
15. A method of generating alveolar organoids using human pluripotent stem cells. Yamamoto Y; Korogi Y; Hirai T; Gotoh S Methods Cell Biol; 2020; 159():115-141. PubMed ID: 32586440 [TBL] [Abstract][Full Text] [Related]
16. Screening of factors inducing alveolar type 1 epithelial cells using human pluripotent stem cells. Ohnishi Y; Masui A; Suezawa T; Mikawa R; Hirai T; Hagiwara M; Gotoh S Stem Cell Reports; 2024 Apr; 19(4):529-544. PubMed ID: 38552636 [TBL] [Abstract][Full Text] [Related]
17. Derivation of self-renewing lung alveolar epithelial type II cells from human pluripotent stem cells. Jacob A; Vedaie M; Roberts DA; Thomas DC; Villacorta-Martin C; Alysandratos KD; Hawkins F; Kotton DN Nat Protoc; 2019 Dec; 14(12):3303-3332. PubMed ID: 31732721 [TBL] [Abstract][Full Text] [Related]
18. Lung Progenitor and Stem Cell Transplantation as a Potential Regenerative Therapy for Lung Diseases. Serna Villa V; Ren X Transplantation; 2024 Oct; 108(10):e282-e291. PubMed ID: 38416452 [TBL] [Abstract][Full Text] [Related]
19. Bone marrow mesenchymal stem cells can differentiate into type II alveolar epithelial cells in vitro. Ma N; Gai H; Mei J; Ding FB; Bao CR; Nguyen DM; Zhong H Cell Biol Int; 2011 Dec; 35(12):1261-6. PubMed ID: 21542803 [TBL] [Abstract][Full Text] [Related]